The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which would have reduced its spending on those drugs by 44 percent.
The weight loss medicines are proving to be a test case for Robert F. Kennedy Jr., the health secretary, in straddling divisions between his supporters and the president.
Robert F. Kennedy Jr., the health secretary, appearing in the Oval Office on Nov. 6 with other health officials, the chief executives of Novo Nordisk and Eli Lilly and others.
Dr. Richard Pazdur, who has been the F.D.A.’s top cancer drug regulator, represents a stabilizing choice for an agency reeling under staff cuts and low morale.
Dr. Richard Pazdur will now lead the Center for Drug Evaluation and Research, which is in charge of regulating most prescription drugs and over-the-counter medicines.
President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.
President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how hard that will be for generic medicines.
Dr. Reddy’s, an Indian generic drugmaker, in March closed its factory in Shreveport, La.
The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.
Kimberly-Clark is gambling that it can outlast the Trump administration’s Tylenol-autism warnings. Kenvue has a broader portfolio of brand-name products like Band-Aid and Neutrogena.
Login
